Purpose: This study aims to investigate the ameliorative effects of boric acid (BA) on cadmium (Cd)-induced hepatotoxicity were investigated in rats. Materials and Methods: Twenty-eight male Wistar albino rats were randomly assigned to four groups (n=7 each): Control; Cd (single oral dose of Cd 15 mg/kg by gavage, no further treatment for 7 days); BA (boric acid 200 mg/kg/day intraperitoneally for 7 days); and Cd+BA (combined cadmium and boric acid). Serum malondialdehyde (MDA) and total oxidant status (TOS) were measured to assess oxidative stress. Results: MDA and TOS levels were highest in the Cd group compared with the other groups, while these levels were reduced in the Cd+BA group. AST levels were significantly elevated in the Cd group (194.42 U/L) compared with the Cd+BA group (110.57 U/L). Similarly, LDH levels were significantly lower in the Cd+BA group. Histopathological evaluation of liver tissues showed markedly higher damage scores in the Cd group, whereas inflammatory and proapoptotic changes were less pronounced in the Cd+BA group. Conclusion: These findings suggest that BA administration after acute Cd exposure may reduce hepatic injury by lowering oxidative stress, inflammation, and apoptosis.
Akpulat et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: